Shell Asset Management’s Pediatrix Medical MD Stock Holding History

Shell Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,302	Closed	-$59K	–	1539
2021 Q1	$59K	Hold	2,302	–	–	﹤0.01%	1371
2020 Q4	$56K	Hold	2,302	–	–	﹤0.01%	1351
2020 Q3	$37K	Hold	2,302	–	–	﹤0.01%	1322
2020 Q2	$39K	Buy	+2,302	New	+$34.1K	﹤0.01%	1295
2017 Q4	–	Sell	-5,140	Closed	-$222K	–	1118
2017 Q3	$222K	Sell	5,140 -332	-6%	-$15.8K	﹤0.01%	1023
2017 Q2	$330K	Sell	5,472 -10,098	-65%	-$599K	0.01%	988
2017 Q1	$1.08M	Buy	15,570 +1,200	+8%	+$83.3K	0.02%	602
2016 Q4	$958K	Hold	14,370	–	–	0.02%	682
2016 Q3	$952K	Hold	14,370	–	–	0.02%	668
2016 Q2	$1.04M	Buy	14,370 +5,151	+56%	+$354K	0.02%	557
2016 Q1	$596K	Buy	9,219 +4,795	+108%	+$318K	0.01%	639
2015 Q4	$317K	Buy	+4,424	New	+$327K	0.01%	782
2015 Q3	–	Sell	-2,345	Closed	-$174K	–	878
2015 Q2	$174K	Buy	+2,345	New	+$169K	﹤0.01%	834

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Shell Asset Management's MD Position: Q2 2021 in Review

Shell Asset Management sold out of Pediatrix Medical (MD) in Q2 2021, closing a stake of 2,302 shares — an estimated $59K sold.

Shell Asset Management first reported a position in MD in Q2 2015 and held it in 13 quarters. The position peaked at $1.08M in Q1 2017. 220 funds tracked by Wall St. Rank hold MD as of Q2 2021.

Shell Asset Management reported no remaining Pediatrix Medical position as of Q2 2021 after selling out during the quarter.
Shell Asset Management sold 2,302 Pediatrix Medical shares in Q2 2021, an estimated $59K.
Shell Asset Management first reported a position in Pediatrix Medical in Q2 2015 and held it in 13 quarters.
Shell Asset Management's Pediatrix Medical position peaked at $1.08M in Q1 2017.
220 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2021.

Based on Shell Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.